Manufacturing growth sees surging demand at CPhI South East Asia3 May 2019
Number of visitors seeking a contract manufacturer was extremely high, with multinational corporations increasingly looking for local partners to expedite market access into the wider region.
SE Asian demand for manufacturing is being driven by recent regulatory changes and increased generics from Indonesia, Malaysia and the Philippines. These prosperous regional conditions were in evidence at the largest ever CPhI South East Asia (8th edition), which closed late last month. The event’s move from Indonesia to Thailand was extremely successful, with the new Bangkok location booming in just its first year of operation.
One of the emerging trends reported by exhibitors was the increased internationalisation, and this was a common theme running throughout the show, whether it was content from sessions about the FDA Framework and requirements for importing APIs to an increased number of regional distributors. In addition, the number of visitors seeking a contract manufacturer was extremely high, further indicative of the internationalisation of the ASEAN pharma industry, with multinational corporations increasingly looking for local partners to expedite market access into the wider region.
The ASEAN’s market is widely expected to see robust growth through 2019 into 2020 in part thanks to its diversity of opportunity. The region features a good mix of rapidly gentrifying healthcare economies in Thailand and Vietnam, coupled advanced economies with significant high-value manufacturing in Singapore, as well as large patient population countries with an ever increasing demand for generics in Malaysia, Indonesia and Philippines.
Often seen as an indicator of ASEAN pharma’s overall health, the success of CPhI South East Asia suggests a thriving pharma sector in the region. Indicative of this region’s overall prosperity, the show has seen an increase of more than 50% in attendees, with almost 7,250 unique attendees and more than 250 exhibitors over 3 days. Such was the strength of the show’s new country, CPhI South East Asia will be moving to the IMPACT, Muang Thong Thani in Bangkok next year where event organisers anticipate an even larger offer onsite and more international visitors.
“It was such a successful edition. The ASEAN pharma market is one that is now brimming with potential and is already reaping the rewards of recent regulatory reforms. CPhI South East Asia has established itself as the region’s business hub, attracting everyone from ingredient suppliers to distributors and CMOs, coming from an increasing diverse range of countries. What is most rewarding is that this show has been integral to industry growth over the last year, with the constant exchanging of ideas and widening business networks playing a pivotal role,” said Marie Lagrenee, Brand Manager at CPhI South East Asia.
In 2020, CPhI South East Asia will co-locate with FDF, ICSE, P-MEC, InnoPack, and NEX South East Asia with Informa expecting to welcome more than 6,000 attendees and 275 exhibitors. Executives attend from across the region’s fastest growing pharma segments, with packaging experts, machinery providers and contract manufacturing, as well as an emerging nutraceutical and laboratory sector – facilitating a collective environment that is helping sustain the next stage in the ASEAN pharma expansion.
Infinium Pharmachem are Exhibiting at CPHI-Worldwide 2019
17 Jul 2019
The company are exhibiting at CPHI Worldwide in Germany on Nov 5-7 2019.Read more
Fresh data on protein interactions in Alzheimer’s disease
2 Jul 2019
Demonstrates the unique ability of diffusional sizing to assess protein binding in-solution and for difficult-to-study systems.Read more
Piramal expands its high potency API capability
25 Jun 2019
Becomes one of only a few companies in the contract development and manufacturing market that can produce HPAPIs at such low OELs.Read more
Inaugural Bio Integrates conference highlights industry's inefficiency in developing products
18 Jun 2019
Industry leaders give voice to issues and trends shaping the biotech sector, including the importance of collaboration.Read more
PASCOE Naturmedizin exhibits at CPhI Worldwide Exhibition in Frankfurt
18 Jun 2019
PASCOE Naturmedizin is one of Germany's 100 most innovative medium-sized enterprises. The success story of our family’s specialist naturopathy company began three generations and almost 125 years ago when Friedrich H. Pascoe's first pharmacy in Mülh...Read more
Liquid pharmaceuticals in the digital age
30 May 2019
Inspiration, innovation and technical highlights from Bosch Packaging Technolgy's Pharmatag 2019.Read more
CPhI China opens with analysis pointing to a surge in growth in 2019
28 May 2019
Regulatory reforms and harmonisation reported as key drivers of industry in China.Read more
Expert forecasts huge growth in Middle East manufacturing
16 May 2019
UAE consumers and insurance companies are willing to pay for highest quality drug products.Read more
Lessons learned from early EU FMD adopters
13 May 2019
Data exchange, investment costs, resources and hardware identified as some of the biggest challenges.Read more
Sirio’s Ayanda launches probiotic softgel
23 Apr 2019
Patent-pending technology is the first ever to enable a softgel capsule to contain both probiotic bacteria and Omega 3 oil.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation